Last reviewed · How we verify

NCT05170490

Long Term Follow up of Chronic HCV Patients Receiving DAAS

Status unknown Last updated 30 June 2022
What this trial tests

trial in Chronic Hepatitis c in 100 participants. Status unknown.

Timeline
1 June 2018
Primary endpoint
1 January 2023
1 March 2023

Quick facts

Lead sponsorSohag University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date1 June 2018
Primary completion1 January 2023
Estimated completion1 March 2023
Sites1 location across Egypt

Conditions studied

Sponsor

Sohag University

Who can join

18 and older, any sex, with Chronic Hepatitis c. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Follow up of Chronic hepatitis C Patients with moderate to severe fibrosis and cirrhosis treated with Direct Acting Antivirals after Sustained Virological Response for 4-5 years to detect changes in hepatic fibrosis and liver functions.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Sohag University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05170490.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing